|
|
Volumn 516, Issue 7529, 2014, Pages 15-16
|
|
Positive results spur race for Ebola vaccine
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
EBOLA VACCINE;
DRUG DEVELOPMENT;
IMMUNE RESPONSE;
MEDICINE;
PUBLIC HEALTH;
VACCINE;
VIRAL DISEASE;
ADENOVIRIDAE;
CD8+ T LYMPHOCYTE;
CHIMPANZEE;
EBOLA HEMORRHAGIC FEVER;
FEVER;
HAPLORHINI;
HUMAN;
IMMUNE RESPONSE;
IMMUNITY;
NONHUMAN;
PHASE 1 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
SHORT SURVEY;
SIDE EFFECT;
VACCINATION;
ACTIVE IMMUNIZATION;
AFRICA;
ANIMAL;
CLINICAL TRIAL (TOPIC);
CYTOLOGY;
EBOLA VIRUS;
GENETICS;
HEMORRHAGIC FEVER, EBOLA;
IMMUNOLOGY;
VACCINIA;
MALI;
AFRICA, WESTERN;
ANIMALS;
CD8-POSITIVE T-LYMPHOCYTES;
CLINICAL TRIALS AS TOPIC;
EBOLA VACCINES;
EBOLAVIRUS;
HAPLORHINI;
HEMORRHAGIC FEVER, EBOLA;
HUMANS;
IMMUNITY, ACTIVE;
VACCINIA;
|
|
EID: 84922329206
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/516015a Document Type: Short Survey |
|
Times cited : (2)
|
|
References (0)
|